The prevention of diabetic retinopathy should involve adequate control of sugar levels, blood pressure, and promoting a ...

Shares of Telomir Pharmaceuticals climbed up 20% to $5.10 after the company said it saw positive pre-clinical results confirming the efficacy of its licensed molecule Telomir-1 in reversing several ...

Up to 40 percent of patients with diabetes mellitus are expected to also develop chronic kidney ... Many people on dialysis complain of itching and say it’s worse during or just after treatment. For ...

Rybelsus in combination with standard T2DM therapy reduced the risk of major cardiovascular events by 14% in patients with ...

MIAMI, FL / / December 3, 2024 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ('Telomir' or the 'Company'), an emerging leader in age-reversal science, today announced groundbreaking preclinical ...

Blood glucose levels decreased very significantly (P = 0.000) from 2.21 ± 0.49 g/l to 1.10 ± 0.20 g/l (Friedman test: P = ...

Eton Pharmaceuticals has acquired the US rights to Amglidia, a treatment developed for neonatal diabetes mellitus, from ...

Background Idiopathic pulmonary fibrosis (IPF) is a disease of progressive lung scarring. There is a known association ...

The drug is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

The food additive carrageenan (E 407) can be responsible for the development of chronic inflammatory bowel disease, ulcers, and increased blood sugar levels in animals. DZD researchers have now ...